HMC Capital Partners Fund I (Fund), is an Australian-domiciled unlisted fund providing exposure to a high-conviction investment strategy seeking to generate superior risk-adjusted returns. 

The Fund will target public and private companies with real asset backing where there is potential to unlock ‘trapped’ value through improved capital allocation and portfolio management.

The Fund is managed by the same team which led the real estate acquisition of Masters from Woolworths Limited in 2017 and who founded HMC Capital, complemented by additional dedicated and high calibre investment professionals.

This Fund will target our highest conviction ideas and leverage our proven investment track record and skills to generate attractive risk adjusted returns which are non-correlated to equity markets over the long-term

 

Investment Strategy

To provide exposure to a portfolio of alternative assets targeting medium to long-term capital growth and income by primarily investing, directly or indirectly across the below key strategy.

High-Conviction Strategic Stakes

Listed Australian and New Zealand entities with the opportunity to take a medium to long term strategic stake and influence change.

Research-led approach to identify undervalued 'asset rich' businesses trading below fundamental value due to:

  • Conglomerate discount
  • Cyclical factors
  • Suboptimal capital allocation / strategic execution

The team will look to assist investee boards and management teams unlock 'trapped' value through improved capital allocation & operational performance.

The Manager may access opportunities across listed and private companies through equity, credit or hybrid instruments.

News & Insights

HMC Capital Partners Fund 1 Upgraded to "Superior" by SQM Research

HMC Capital Partners Fund 1 releases December 2024 Quarterly Investor Update

HMC Capital Partners Retail Fund 1 recognised amongst top Australia's 10 Best Performing Funds of 2024

Our thoughts on Ingenia Communities - A compelling investment opportunity in a growing sector

Selected Case Studies

Sigma Healthcare

Sigma Healthcare

Sigma Healthcare logo
BabyBunting

BabyBunting

BabyBunting logo

Key Fund Features

Feature Detail
Fund Inception 31 August 2022
Unit Pricing Frequency Monthly
Target Return1 15%+ net IRR per annum measured over a 3 to 5 year holding period.
Target Distribution Yield1 Not applicable. The Fund is not expected to make regular distributions, however the Trustee will be required to distribute any net income and net capital gains to Unitholders on an annual basis.
Manager Participation As at 30 April 2025, HMC Capital had $220m invested in the Fund.
Concentration The Fund will invest in HMC Capital's best and highest conviction ideas and will target a highly concentrated portfolio of primarily listed investments2.
Available to Investors who meet the definition of a wholesale investor and who have a minimum investment amount of $100,000
Fees Management fee: 1.0% p.a. of NAV
Performance fee: 20% performance fee above 9% p.a. hurdle rate subject to a high-water mark3.
Buy / Sell Spread 0.30% / 0.30%
Applications Monthly applications with instructions to be sent through 10 business days before month end. 
Redemptions Quarterly on the last business day of Mar, Jun, Sept, and Dec with 90 days' prior notice. Redemptions will be subject to a limit of 5% of the fund units outstanding at the end of each quarter.
Platform availability Mason Stevens, Netwealth, Powerwrap, HUB24
Ratings4,5   
  1. Target Return is net of base management fees and costs but before tax (if applicable) and performance fees. This is only a target and may not be achieved.
  2. The Fund has the flexibility to hold up to 25% unlisted assets should that arise from execution of listed investment value maximization strategy.
  3. The hurdle return for periods prior to 1 July 2025 was 7% per annum.
  4. The rating is issued by SQM Research Pty Ltd ABN 93 122 592 036 AFSL 421913. SQM Research is an investment research firm that undertakes research on investment products exclusively for its wholesale clients, utilising a proprietary review and star rating system. The SQM Research star rating system is of a general nature and does not take into account the particular circumstances or needs of any specific person. The rating may be subject to change at any time. Only licensed financial advisers may use the SQM Research star rating system in determining whether an investment is appropriate to a person's particular circumstances or needs. You should read the information memorandum and consult a licensed financial adviser before making an investment decision in relation to this investment product. SQM Research receives a fee from the Fund Manager for the research and rating of the managed investment scheme.
  5. The ratings published on 10/2025 for HMC8690AU and HMC5977AU are issued by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421 445 (Lonsec Research). Ratings are general advice only and have been prepared without taking account of investors' objectives, financial situation or needs. Consider your personal circumstances, read the product disclosure statement and seek independent financial advice before investing. The ratings are not a recommendation to purchase, sell or hold any product. Past performance information is not indicative of future performance. Ratings are subject to change without notice and Lonsec Research assumes no obligation to update. Lonsec Research uses objective criteria and receives a fee from the Fund Manager. Visit lonsec.com.au for ratings information and to access the full report. © 2025 Lonsec. All rights reserved.

Performance

As at 30 November 2025i

  1mth 3mth 6mth 1yr 2yr 3yr Inception - p.a Inception - Cumulative
HMC Capital Partners Fund 1 (2.9)% (3.3)% (0.6)% (2.6)% 43.3% 26.3% 26.0% 112.1%

Unit price

  Net Asset Value per unit Entry Price Exit Price
As at 30 November 2025 $1.2608 $1.2646 $1.2570 

Accumulated performance

All performance figures used in the calculation of the accumulated returns are quoted net of fees and costs and assumes reinvestment of distributions. Performance is shown for informational purposes only. Past performance should not be taken as an indicator of future performance. Total return is calculated assuming $100,000 has been invested at the inception of the Fund on 31 August 2022.
The S&P/ ASX 300 Accumulation Index has been included for comparison purposes. The Fund is managed on an absolute return basis and does not have a nominated benchmark.
Past performance is not a reliable indicator of future performance.

Fund NAVii

% Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2022 n/a n/a n/a n/a n/a n/a n/a $1.0000 $1.0372 $1.0269 $1.0534 $1.0348
2023 $1.0740 $1.0681 $1.0596 $1.0760 $1.0696 $1.1692 $1.1943 $1.1636 $1.0717 $0.9459 $1.0317 $1.2738
2024 $1.3573 $1.4177 $1.5522 $1.4991 $1.4602 $1.4512 $1.5507 $1.5689 $1.6840 $1.8659 $2.1784 $1.9891
2025 $2.1959 $2.1152 $2.0487 $1.1793iii $1.2686 $1.2389 $1.1159 $1.3043 $1.3236 $1.2987 $1.2608  

Distributions per unit

Distribution date Distribution per unit
April 2025 $0.805

All unit prices and investment returns quoted are for the HMC Capital Partners Fund 1 - Trust A

  1. All performance figures are quoted net of fees and costs. Figures may not sum exactly due to rounding. Inception date 31 August 2022. Performance is shown for informational purposes only. Past performance should not be taken as an indicator of future performance.
  2. As at month-end
  3. NAV reflects the payment of the $0.805/unit interim distribution in mid-April 2025. Cum distribution NAV is $1.9843/unit as at 30 April 2025

How to invest

Reports

Get Email alerts

Load more

The Team

Trustee Board

Jingmin Qian

Jingmin Qian

Chair and Independent Trustee Director

Rachel Grimes AM

Rachel Grimes AM

Independent Trustee Director

Natalie Meyenn

Natalie Meyenn

Independent Trustee Director

Fiona Pak-Poy

Fiona Pak-Poy

Trustee Director

David Di Pilla

David Di Pilla

Trustee Director

Investment Committee

David Di Pilla

David Di Pilla

Chair of Investment Committee

Fiona Pak-Poy

Fiona Pak-Poy

Non-Executive Director

Dr Chris Roberts AO

Dr Chris Roberts AO

Non-Executive Director

Jingmin Qian

Jingmin Qian

Independent Trustee Director

Rachel Grimes AM

Rachel Grimes AM

Independent Trustee Director

Natalie Meyenn

Natalie Meyenn

Independent Trustee Director

Management Team

David Di Pilla

David Di Pilla

Managing Director and Group Chief Executive Officer

Victoria Hardie

Victoria Hardie

Group Chief Operating Officer and Head of Private Equity

Joshua Gal

Joshua Gal

Portfolio Manager

Misha Mohl

Misha Mohl

Managing Director, Strategy and Corporate Development

Jamie Sun

Jamie Sun

Executive Director

Lan Do

Lan Do

Senior Associate

Rita Mikhael

Rita Mikhael

Head of Legal - Digital Infrastructure & Private Equity

Enquiries

Contact us for more information on the fund or how to invest:

Investor Information

1. Link to Automic

If you are a Wholesale Client, you may apply via the general offer link:
https://investor.automic.com.au/#/w/hmccp 

2. Contact our Team

E: invest@hmccapital.com.au